Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EXPAND: A Prospective Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With End-stage Renal Disease (ESRD)

NCT06878560 is registered in ClinicalTrials.gov with United Therapeutics as lead sponsor.

NCT NCT06878560
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06878560 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EXPAND: A Prospective Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With End-stage Renal Disease (ESRD)
Lead sponsor
United Therapeutics
Phase
Phase 1/2
Overall status
Recruiting
Start date
October 29, 2025
Completion date
October 31, 2075
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

esrd (end-stage renal disease), kidney transplantation, xenotransplantation